An observational study in Neurocognitive Deficit, sponsored by Universidade Federal do Rio Grande do Norte. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Universidade Federal do Rio Grande do Norte · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The objective of this observational study is to assess the efficacy of two neuropsychological tests (MoCA-B and MoCA-Blind) in detecting cognitive decline in older adults. The main questions it aims to answer are:
Can the results obtained by older adults on the MoCA-B distinguish between those with and without cognitive decline? Can the results obtained by older adults on the MoCA-Blind distinguish between those with and without cognitive decline?
Participants will be required to: 1. Complete a sociodemographic questionnaire; 2. Undergo a visual acuity test; 3. Complete the Pfeffer and IQCODE scales; and 4. Complete the MMSE, MoCA-B, and MoCA-Blind.
361 studies on the registry are indexed under Vision Disorders; 85 are open to participants now.
This study's planned enrollment of 124 is close to the median of 126 across 97 observational studies indexed under Vision Disorders.
Browse Vision Disorders studies →Universidade Federal do Rio Grande do Norte is the lead sponsor of 86 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Older adults (60 years or older) with and without cognitive decline and with and without visual impairment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Optimal cut-off score for the MoCA-B and MoCA-Blind
The scores obtained by the participants (0 to 30) will be used to calculate the ROC curve and determine the optimal cutoff point (highest sensitivity and specificity) to distinguish between cognitive decline and healthy individuals.
Time frame: Assessed at baseline (Day 0)
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Federal do Rio Grande do Norte